Nominations should include a one-page letter explaining the reasons for the nomination.
Current elected officials are not eligible.
Honorees are selected for their local impact, breadth of contribution, the diversity of people affected, timeliness and originality of contributions.
More information, including the nomination form, is available from the Chamber website at paloaltochamber.com/tall-tree-awards.
The deadline for submitting nominations is Jan. 15, 2023. The Tall Tree Awards dinner, which raises money for the Chamber, will be held on April 20.
Hopes dim for restoring former Fry's building
When Palo Alto leaders struck a deal with The Sobrato Organization in June to redevelop the large Ventura property on Portage Avenue that used to house Fry's Electronics, the developer agreed to preserve and enhance a portion of the building that a century ago stood out as the world's third largest cannery of fruits and vegetables.
Since then, however, the prospects of preserving the cannery have dimmed. On Wednesday night, the Planning and Transportation Commission learned that portions of the building were in worse condition than was previously believed and that the structure cannot retain historic features while complying with modern building codes.
Whether or not the development agreement advances, the building is set to undergo major renovations that would render it ineligible for possible inclusion on the state Register of Historic Places. Sobrato plans to demolish about a third of it to construct a townhome development.
If the city approves the agreement, the development would consist of 74 townhomes. Sobrato would also donate to the city 3.25 acres of land to make room for a park and a future affordable-housing development.
If the city rejects the development agreement, Sobrato is expected to advance a housing project that it applied for more than two years ago, which includes 91 townhomes. Under Senate Bill 330, the city's ability to request modifications for the project is restricted.
After a long discussion, the commission voted 5-1 to advance the development agreement process. In doing so, however, numerous commissioners indicated that they are unlikely to support the agreement when it returns to the commission for a formal decision early next year.
Stanford's president accused of scientific misconduct
Stanford University announced this week that it will investigate allegations of scientific misconduct involving its president, Marc Tessier-Lavigne, after an independent student news outlet published an article detailing suspected problems with research papers where he's listed as an author.
The Stanford Daily's article published on Tuesday explored possible image manipulation in four papers, including two where Tessier-Lavigne is the lead author.
"There appear to be a lot of visible errors in these papers, and some duplications are suggestive (of) an intention to mislead," Scientific misconduct expert Elisabeth Bik said in the Daily article.
University spokesperson Dee Mostofi confirmed to this news organization on Wednesday that Stanford would be launching its own review.
"In the case of the papers in question that list President Tessier-Lavigne as an author, the process will be overseen by the Board of Trustees," Mostofi wrote in an email.
Mostofi released a quote attributed to Tessier-Lavigne, backing Stanford's investigation.
"Scientific integrity is of the utmost importance both to the university and to me personally," Tessier-Lavigne said. "I support this process and will fully cooperate with it, and I appreciate the oversight by the Board of Trustees."
In the case of one of the papers, in which Tessier-Lavigne is listed among 11 authors, the research journal in which it was published has publicly said that it is looking into the issues. The EMBO Journal's editor-in-chief told the Daily that it was doing a "full due diligence screen" of the 2008 paper.
Tessier-Lavigne came to Stanford in 2016 after previously serving as president of The Rockefeller University in New York City. Before that, he worked as an executive at the biotech company Genentech.
His neuroscience research involved the study of brain development and repair, with a focus on degenerative brain diseases like Alzheimer's disease and Parkinson's disease, according to his biography on Stanford's website.
This story contains 698 words.
Stories older than 90 days are available only to subscribing members. Please help sustain quality local journalism by becoming a subscribing member today.
If you are already a member, please log in so you can continue to enjoy unlimited access to stories and archives. Membership start at $12 per month and may be cancelled at any time.